Cargando…

Recurrent and metastatic squamous cell carcinoma in lung transplant recipient on voriconazole: Lessons learned

Detalles Bibliográficos
Autores principales:	Zhang, Shali, Neujahr, David C., Zwald, Fiona O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4809587/ https://www.ncbi.nlm.nih.gov/pubmed/27051799 http://dx.doi.org/10.1016/j.jdcr.2015.09.015

Ejemplares similares

Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States
por: D’Arcy, Monica E., et al.
Publicado: (2020)

Voriconazole-induced Myositis in a Double Lung Transplant Recipient
por: Soliman, Mohanad, et al.
Publicado: (2019)

1129. Targeted Voriconazole Prophylaxis in Heart Transplantation Recipients
por: Lin, Michael, et al.
Publicado: (2018)

Antifungal prophylactic effectiveness and intrapulmonary concentrations of voriconazole versus posaconazole in lung transplant recipients
por: Ju, Chunrong, et al.
Publicado: (2022)

Skin Cancer in the Crosshairs: Highlights from the Biennial Scientific Retreat of International Transplant Skin Cancer Collaborative and Skin Care in Organ Transplant Recipients Europe
por: Sinnya, Sudipta, et al.
Publicado: (2015)

Effective Prolonged Therapy with Voriconazole in a Lung Transplant Recipient with Spondylodiscitis Induced by Scedosporium apiospermum
por: Luijk, B., et al.
Publicado: (2011)

Fusarium Infection in a Kidney Transplant Recipient Successfully Treated with Voriconazole
por: Alkhunaizi, Ahmed M., et al.
Publicado: (2018)

Voriconazole-induced periostitis post lung transplantation
por: Murray, Orla M., et al.
Publicado: (2022)

Predictors of Adverse Events and Determinants of the Voriconazole Trough Concentration in Kidney Transplantation Recipients
por: Zhao, Yi‐Chang, et al.
Publicado: (2020)

The Effect of Voriconazole on Tacrolimus in Kidney Transplantation Recipients: A Real-World Study
por: Zhao, Yi-Chang, et al.
Publicado: (2022)

Voriconazole Induced Cutaneous Squamous Cell Carcinoma in an Immunocompetent Patient
por: Parza, Kevin, et al.
Publicado: (2022)

The incidence of cutaneous squamous cell carcinoma in patients receiving voriconazole therapy for chronic pulmonary aspergillosis
por: Kosmidis, Chris, et al.
Publicado: (2020)

Topical 1% Voriconazole for Mixed Scedosporium and Exophiala Subcutaneous Infection in a Kidney Transplant Recipient
por: PACCOUD, Olivier, et al.
Publicado: (2023)

Cutaneous Squamous Cell Carcinomas in Organ Transplant Recipients
por: Chockalingam, Ramya, et al.
Publicado: (2015)

Disseminated Trichosporon asahii infection in a combined liver‐kidney transplant recipient successfully treated with voriconazole
por: Sah, Ranjit, et al.
Publicado: (2019)

Impact of CYP2C19 Genotype and Liver Function on Voriconazole Pharmacokinetics in Renal Transplant Recipients
por: Li, Zi-Wei, et al.
Publicado: (2017)

1291. Safety of Isavuconazole Compared with Voriconazole as Primary Antifungal Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients
por: Bogler, Yael, et al.
Publicado: (2020)

Voriconazole-Induced Squamous Cell Carcinoma after Hematopoietic Stem Cell Transplantation Showing Early-Stage Vascular Invasion
por: Sawada, Yumi, et al.
Publicado: (2020)

Real-World Experience of Voriconazole Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Single-Center Study
por: Chan, Shuk-Ying, et al.
Publicado: (2017)

Squamous cell carcinoma of tongue in a renal transplant recipient
por: Malleshappa, Pavan, et al.
Publicado: (2009)

Keratoacanthoma Accompanied by Multiple Lung Squamous Cell Carcinomas Developing in a Renal Transplant Recipient
por: Furudate, Sadanori, et al.
Publicado: (2014)

Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
por: Van Meerhaeghe, T., et al.
Publicado: (2022)

Immune checkpoint inhibitor therapy in a liver transplant recipient with autoimmune disease and metastatic cutaneous squamous cell carcinoma
por: Brumfiel, Caitlin M., et al.
Publicado: (2021)

89. Efficacy and Tolerability of Voriconazole (VOR) vs. Isavuconazole (ISA) Prophylaxis (px) in Preventing Invasive Fungal Infections (IFI) in Lung Transplant Recipients (LTR)
por: Samanta, Palash, et al.
Publicado: (2019)

Demethylation of the TSDR Is a Marker of Squamous Cell Carcinoma in Transplant Recipients
por: Sherston, S N, et al.
Publicado: (2014)

Capecitabine for squamous cell carcinoma reduction in solid organ transplant recipients
por: Breithaupt, Andrew D., et al.
Publicado: (2015)

Changes in the skin microbiome associated with squamous cell carcinoma in transplant recipients
por: Krueger, Annika, et al.
Publicado: (2022)

Multifocal Aggressive Squamous Cell Carcinomas Induced by Prolonged Voriconazole Therapy: A Case Report
por: Morice, C., et al.
Publicado: (2010)

Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward
por: Habibi, Shaghayegh, et al.
Publicado: (2023)

Tacrolimus Concentration after Letermovir Initiation in Hematopoietic Stem Cell Transplantation Recipients Receiving Voriconazole: A Retrospective, Observational Study
por: Hikasa, Shinichi, et al.
Publicado: (2020)

Incidentally Detected Malignancies in Lung Transplant Explants
por: Amratia, Dhruv A., et al.
Publicado: (2019)

Pre-Transplant Factors Influencing Rates of Hepatocellular Carcinoma Recurrence in Liver Transplant Recipients
por: Zucker, Kelly M., et al.
Publicado: (2021)

Immunosuppression in a lung transplant recipient with COVID-19? Lessons from an early case
por: Raëth, J., et al.
Publicado: (2020)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Cost Analysis of the Use of Voriconazole, Posaconazole and Micafungin in the Primary Prophylaxis of Invasive Fungal Infections in Recipients of Allogeneic Hematopoietic Stem Cell Transplants
por: Grau, Santiago, et al.
Publicado: (2015)

Use of machine learning models for identification of predictors of survival and tumour recurrence in liver transplant recipients with hepatocellular carcinoma
por: Bezjak, Miran, et al.
Publicado: (2023)

A systematic review and meta-analysis of COVID-19 in kidney transplant recipients: Lessons to be learned
por: Kremer, Daan, et al.
Publicado: (2021)

Squamous cell carcinomas in organ transplant recipients. Comparison of histopathological and clinical features of squamous cell carcinoma in patients after organ transplantation to immunocompetent patients
por: Renczyñska-Matysko, Joanna, et al.
Publicado: (2022)

Decreased cytotoxic T cells and TCR clonality in organ transplant recipients with squamous cell carcinoma
por: Frazzette, Nicholas, et al.
Publicado: (2020)

The Tumor Immune Microenvironment in Cutaneous Squamous Cell Carcinoma Arising in Organ Transplant Recipients
por: Zilberg, Catherine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7emcsfhi6gv4bgdc87rmr85895